Retraction notice (Biological Psychiatry (2015) 78(10) (693–701), (S0006322315000840), (10.1016/j.biopsych.2015.01.015));Pharmacologic Inhibition of 5-Lipoxygenase Improves Memory, Rescues Synaptic Dysfunction, and Ameliorates Tau Pathology in a Transgenic Model of Tauopathy

Biological Psychiatry

Volumn 78, Issue 10, 2015, Pages 693-701

  Giannopoulos, Phillip F ^a,c   Chu, Jin ^a,c   Sperow, Margaret ^b   Li, Jian Guo ^a,c   Yu, W Haung ^e   Kirby, Lynn G ^b,d   Abood, Mary ^b,d   Praticò, Domenico ^a,c  

^a Center for Translational Medicine   (United States)

^b Center for Substance Abuse Research   (United States)

^c Department of Pharmacology ^*  (United States)

^d TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Department of Medicine   (United States)

Author keywords

5 Lipoxygenase; Behavior; Frontotemporal dementia; Synapse; Tau protein; Tauopathy; Transgenic tau mice

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; CYCLIN DEPENDENT KINASE 5; GLYCOGEN SYNTHASE KINASE 3; LEUKOTRIENE B4; MICROTUBULE ASSOCIATED PROTEIN 2; PHOSPHOPROTEIN PHOSPHATASE 2A; POSTSYNAPTIC DENSITY PROTEIN 95; PYRIDOXAL 5 PHOSPHATE; SYNAPTOPHYSIN; ZILEUTON; HYDROXYUREA; LIPOXYGENASE INHIBITOR; MAPT PROTEIN, HUMAN; TAU PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; EXCITATORY POSTSYNAPTIC POTENTIAL; HIPPOCAMPAL CA1 REGION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LATENT PERIOD; LONG TERM POTENTIATION; MEMORY; MORRIS WATER MAZE TEST; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; PATHOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SPATIAL MEMORY; SYNAPSE; SYNAPTIC TRANSMISSION; TAUOPATHY; UPREGULATION; WESTERN BLOTTING; WORKING MEMORY; Y-MAZE TEST; ANALOGS AND DERIVATIVES; ANIMAL; BRAIN; C57BL MOUSE; CEREBELLUM; DISEASE MODEL; DRUG EFFECTS; ENCEPHALITIS; ENZYMOLOGY; GENETICS; METABOLISM; NERVE CELL; PHOSPHORYLATION; PHYSIOLOGY; TRANSGENIC MOUSE;

ANIMALS; ARACHIDONATE 5-LIPOXYGENASE; BRAIN; CEREBELLUM; CEREBRAL CORTEX; CYCLIN-DEPENDENT KINASE 5; DISEASE MODELS, ANIMAL; ENCEPHALITIS; EXCITATORY POSTSYNAPTIC POTENTIALS; HUMANS; HYDROXYUREA; LIPOXYGENASE INHIBITORS; MEMORY; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEURONS; PHENOTYPE; PHOSPHORYLATION; SYNAPSES; TAU PROTEINS; TAUOPATHIES;

EID: 84945166246     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2024.05.002     Document Type: Erratum

References (26)

1. K. Iqbal, F. Liu, C.X. Gong, and I. Grundke-Iqbal Tau in Alzheimer disease and related tauopathies Curr Alzheimer Res 7 2010 656 664
2. M.G. Spillantini, and M. Goedert Tau pathology and neurodegeneration Lancet Neurol 12 2013 609 622
3. K. Ishizawa, and D.W. Dickson Microglial activation parallels system degeneration in progressive supranuclear palsy and corticobasal degeneration J Neuropathol Exp Neurol 60 2001 647 657
4. M. Kitazawa, S. Oddo, T.R. Yamasaki, K.N. Green, and F.M. LaFerla Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease J Neurosci 25 2005 8843 8853
5. K. Bhaskar, M. Konerth, O.N. Kokiko-Cochran, A. Cardona, R.M. Ransohoff, and B.T. Lamb Regulation of tau pathology by the microglial fractalkine receptor Neuron 68 2010 19 31
6. C.M. Chinnici, Y. Yao, and D. Pratico The 5-lipoxygenase enzymatic pathway in the mouse brain: Young versus old Neurobiol Aging 28 2007 1457 1462
7. J. Chu, and D. Pratico Pharmacologic blockade of 5-lipoxygenase improves the amyloidotic phenotype of an Alzheimer's disease transgenic mouse model involvement of gamma-secretase Am J Pathol 178 2011 1762 1769
8. J. Chu, P.F. Giannopoulos, C. Ceballos-Diaz, T.E. Golde, and D. Pratico Adeno-associated virus-mediated brain delivery of 5-lipoxygenase modulates the AD-like phenotype of APP mice Mol Neurodegener 7 2012 1
9. J. Chu, P.F. Giannopoulos, C. Ceballos-Diaz, T.E. Golde, and D. Pratico 5-Lipoxygenase gene transfer worsens memory, amyloid, and tau brain pathologies in a mouse model of Alzheimer disease Ann Neurol 72 2012 442 454
10. J. Chu, J.G. Li, and D. Pratico Zileuton improves memory deficits, amyloid and tau pathology in a mouse model of Alzheimer's disease with plaques and tangles PLoS One 8 2013 e70991
11. P.F. Giannopoulos, J. Chu, Y.B. Joshi, M. Sperow, J.G. Li, L.G. Kirby, and et al. Gene knockout of 5-lipoxygenase rescues synaptic dysfunction and improves memory in the triple-transgenic model of Alzheimers disease Mol Psychiatry 19 2014 511 518
12. C. Andorfer, Y. Kress, M. Espinoza, R. de Silva, K.L. Tucker, Y.A. Barde, and et al. Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms J Neurochem 86 2003 582 590
13. G. Riccioni, C. Di Ilio, P. Conti, T.C. Theoharides, and N. D'Orazio Advances in therapy with antileukotriene drugs Ann Clin Lab Sci 34 2004 379 387
14. P.F. Giannopoulos, J. Chu, Y.B. Joshi, M. Sperow, J.G. Li, L.G. Kirby, and et al. 5-Lipoxygenase activating protein reduction ameliorates cognitive deficit, synaptic dysfunction, and neuropathology in a mouse model of Alzheimer's disease Biol Psychiatry 74 2013 348 356
15. M. Polydoro, C.M. Acker, K. Duff, P.E. Castillo, and P. Davies Age-dependent impairment of cognitive and synaptic function in the htau mouse model of tau pathology J Neurosci 29 2009 10741 10749
16. C.L. Weaver, M. Espinoza, Y. Kress, and P. Davies Conformational change as one of the earliest alterations of tau in Alzheimers disease Neurobiol Aging 21 2000 719 727
17. R.S. Zucker, and W.G. Regehr Short-term synaptic plasticity Annu Rev Physiol 64 2002 355 405
18. T.V. Bliss, and G.L. Collingridge A synaptic model of memory: Long-term potentiation in the hippocampus Nature 361 1993 31 39
19. M.J. Alldred, K.E. Duff, and S.D. Ginsberg Microarray analysis of CA1 pyramidal neurons in a mouse model of tauopathy reveals progressive synaptic dysfunction Neurobiol Dis 45 2012 751 762
20. K. Duff, H. Knight, L.M. Refolo, S. Sanders, X. Yu, M. Picciano, and et al. Characterization of pathology in transgenic mice over-expressing human genomic and cDNA tau transgenes Neurobiol Dis 7 2000 87 98
21. K. Santacruz, J. Lewis, T. Spires, J. Paulson, L. Kotilinek, M. Ingelsson, and et al. Tau suppression in a neurodegenerative mouse model improves memory function Science 309 2005 476 481
22. S. Oddo, A. Caccamo, M. Kitazawa, B.P. Tseng, and F.M. LaFerla Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimers disease Neurobiol Aging 24 2003 1063 1070
23. S. Oddo, A. Caccamo, D. Cheng, and F.M. LaFerla Genetically altering Abeta distribution from the brain to the vasculature ameliorates tau pathology Brain Pathol 19 2009 421 430
24. I. Kelleher, C. Garwood, D.P. Hanger, B.H. Anderton, and W. Noble Kinase activities increase during the development of tauopathy in htau mice J Neurochem 103 2007 2256 2267
25. H.C. Dunn, R.R. Ager, D. Baglietto-Vargas, D. Cheng, M. Kitazawa, D.H. Cribbs, and et al. Restoration of lipoxin A4 signaling reduces Alzheimers disease-like pathology in the 3xTg-AD mouse model J Alzheimers Dis 43 2015 893 903
26. E.R. Kandel, and J.H. Schwartz Molecular biology of learning: Modulation of transmitter release Science 218 1982 433 443